Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: An individual patient data meta-analysis

Acta Psychiatrica Scandinavica

Volumn 128, Issue 3, 2013, Pages 149-162

  Bourne, C ^a,b   Aydemir, O ^c   Balanza Martinez V ^d   Bora, E ^e   Brissos, S ^f,g   Cavanagh, J T O ^h   Clark, L ⁱ   Cubukcuoglu, Z ^j   Dias, V V ^k   Dittmann, S ^l   Ferrier, I N ^m   Fleck, D E ⁿ   Frangou, S ^o   Gallagher, P ^m   Jones, L ^p   Kieseppa T ^q,r   Martinez Aran A ^s   Melle, I ^t,u   Moore, P B ^m   Mur, M ^v   Pfennig, A ^w   Raust, A ^x   Senturk, V ^y   Simonsen, C ^t,u   Smith, D J ^z   Bio, D S ^aa   Soeiro de Souza, M G ^aa   Stoddart, S D R ^p   Sundet, K ^t,u   Szoke A ^x,ab   Thompson, J M ^m   Torrent, C ^s   Zalla, T ^ac   Craddock, N ^z   Andreassen, O A ^t,u   Leboyer, M ^x,ab   Vieta, E ^s   Bauer, M ^w   Worhunsky, P D ^a   Tzagarakis, C ^a   Rogers, R D ^a   Geddes, J R ^a   Goodwin, G M ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NEWMAN UNIVERSITY   (United Kingdom)

^c CELAL BAYAR UNIVERSITY   (Turkey)

^d UNIVERSITY OF VALENCIA   (Spain)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f Lisbon's Psychiatric Hospitalar Centre   (Portugal)

^g Janssen Pharmaceutical   (Portugal)

^h UNIVERSITY OF GLASGOW   (United Kingdom)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j Department of Child and Adolescent Psychiatry   (Germany)

^k INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^l UNIVERSITY OF MUNICH   (Germany)

^m NEWCASTLE UNIVERSITY   (United Kingdom)

ⁿ UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

^o MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^q NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^r PEIJAS HOSPITAL   (Finland)

^s UNIVERSITY OF BARCELONA   (Spain)

^t ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^u UNIVERSITY OF OSLO   (Norway)

^v UNIVERSITY OF LLEIDA   (Spain)

^w UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^x HENRI MONDOR HOSPITAL   (France)

^y ANKARA UNIVERSITY   (Turkey)

^z CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^aa UNIVERSITY OF SÃO PAULO   (Brazil)

^ab INSERM U955   (France)

^ac INSTITUT JEAN NICOD   (France)

more..

Author keywords

Bipolar disorder; Cognitive impairment; Neuropsychological tests; Review

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; LITHIUM; NEUROLEPTIC AGENT;

AGE; ARTICLE; BIPOLAR DISORDER; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; EUTHYMIC BIPOLAR DISORDER; EXECUTIVE FUNCTION; GENDER; HUMAN; INTELLIGENCE QUOTIENT; LEARNING; MEMORY; META ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHOLOGICAL TEST; PATIENT CODING; PRIORITY JOURNAL; PSYCHOLOGIC TEST; REVERSE DIGIT SPAN; TASK PERFORMANCE; TRAIL MAKING TEST B; WECHSLER INTELLIGENCE SCALE; WECHSLER MEMORY SCALE; WISCONSIN CARD SORTING TEST;

BIPOLAR DISORDER; COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; REVIEW;

ADULT; AFFECT; AFFECTIVE SYMPTOMS; AGE OF ONSET; BIPOLAR DISORDER; COGNITION DISORDERS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; MALE; MENTAL COMPETENCY; MENTAL PROCESSES; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTROPIC DRUGS; RISK FACTORS;

EID: 84881498049     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12133     Document Type: Article

References (78)

1. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: A critical review. Bipolar Disord 2001;3:106-150.
2. Quraishi S, Frangou S. Neurospychology of bipolar disorder. J Affect Disord 2002;72:209-226.
3. Savitz J, Solms M, Ramesar RS. Neuropsychological dysfunction in bipolar affective disorder: a critical opinion. Bipolar Disord 2005;7:216-235.
4. Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004;161:262-270.
5. Goodwin GM, Anderson I, Arango C et al. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol 2008;18:535-549.
6. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2007;38:771-785.
7. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009;113:1-20.
8. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006;93:105-115.
9. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand 2007;116:17-26.
10. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 2006;8:103-116.
11. Krabbendam L, Arts B, van Os J, Aleman A. Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophr Res 2005;80:137-149.
12. Mann-Wrobel MC, Carreno JT, Dickinson D. Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord 2011;13:334-342.
13. Kurtz MM, Gerraty RT. A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. Neuropsychology 2009;5:551-562.
14. The Psychiatric GWAS Consortium Steering Committee. A framework for interpreting genome-wide association studies of psychiatric disorders. Mol Psychiatry 2009;14:10-17.
15. Rivas MA, Beaudoin M, Gardet A et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011;43:1066-1075.
16. Belmonte Mahon P, Pirooznia M, Goes FS et al. Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2011;156:370-378.
17. Clarke MJ. Individual patient data meta-analyses. Best Pract Res Clin Obstet Gynaecol 2005;19:47-55.
18. Delis DC, Kramer JH, Kaplan E, Ober BA. California verbal learning test: adult version. San Antonio, TX: The Psychological Corporation, 1987.
19. Rey A. L'examen clinique en psychologie. Paris: Presses Universitaires de France, 1964.
20. Reitan RM. Validity of trail making test as an indication of organic brain disease. Percept Mot Skills 1958;8:271-276.
21. Wechsler D. Wechsler adult intelligence scale - revised: manual. New York: Psychological Corporation, 1981.
22. Heaton RK. Wisconsin card sorting test manual. Odessa, FL: Psychological Assessment Resources Inc., 1981.
23. Yatham LN, Torres IJ, Malhi GS et al. The International Society for Bipolar Disorders - battery for assessment of neurocognition (ISBD-BANC). Bipolar Disord 2010;12:351-363.
24. Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 2009;62:1006-1012.
25. Simonsen C, Sundet K, Vaskinn A et al. Neurocognitive profiles in bipolar I and bipolar II disorder: differences in pattern and magnitude of dysfunction. Bipolar Disord 2008;10:245-255.
26. Balanza-Martinez V, Tabares-Seisdedos R, Selva-Vera G et al. Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom 2005;74:113-119.
27. Bora E, Vahip S, Akdeniz F et al. The effect of previous psychotic mood episodes on cognitive impairment in euthymic bipolar patients. Bipolar Disord 2007;9:468-477.
28. Cavanagh JTO, van Beck M, Muir M, Blackwood DHR. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002;180:320-326.
29. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002;180: 313-319.
30. Dittmann S, Seemuller F, Schwarz MJ et al. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disord 2007;9:63-70.
31. El-Badri SM, Ashton CH, Moore PB, Marsh VR, Ferrier IN. Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord 2001;3:79-87.
32. Fleck DE, Shear PK, Zimmerman ME et al. Verbal memory in mania: effects of clinical state and task requirements. Bipolar Disord 2003;5:375-380.
33. Fleck DE, Shear PK, Madore M, Strakowski SM. Wisconsin card sorting test performance in bipolar disorder: effects of mood state and early course. Bipolar Disord 2008;10:539-545.
34. Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH. The Maudsley bipolar disorder project: executive dysfunction in bipolar I disorder and its clinical correlates. Biol Psychiatry 2005;58:859-864.
35. Goswami U, Sharma A, Khastigir U et al. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry 2006;188:366-373.
36. Kieseppa T, Tuulio-Henriksson A, Haukka J et al. Memory and verbal learning functions in twins with bipolar-I disorder and the role of information-processing speed. Psychol Med 2005;35:205-215.
37. Martinez-Aran A, Vieta E, Torrent C et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007;9:103-113.
38. Mur M, Portella MJ, Martinez-Aran A, Pifarre J, Vieta E. Persistant neuropsychological deficit in euthymic bipolar patients: executive function as a core deficit. J Clin Psychiatry 2007;68:1078-1086.
39. Senturk V, Goker C, Bilgic A et al. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord 2007;9:136-144.
40. Smith DJ, Muir WJ, Blackwood DHR. Neurocognitive impairment in euthymic young adults with bipolar spectrum disorder and recurrent major depressive disorder. Bipolar Disord 2006;8:40-46.
41. Stoddart SDR, Craddock NJ, Jones LA. Differentiation of executive function and attention impairments in affective illness. Psychol Med 2007;37:1613-1623.
42. Szoke A, Schurhoff F, Golmard J et al. Familial resemblance for executive functions in families of schizophrenic and bipolar patients. Psychiatry Res 2006;144:131-138.
43. Thompson JM, Gallagher P, Hughes JH et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005;186:32-40.
44. Torrent C, Martinez-Aran A, Daban C et al. Cognitive impairment in bipolar II disorder. Br J Psychiatry 2006;189:254-259.
45. Zalla T, Joyce C, Szoke A et al. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res 2004;121:207-217.
46. Dias VV, Brissos S, Frey BN, Andreazza AC, Cardoso C, Kapczinski F. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord 2009;11:663-671.
47. Simonsen C, Sundet K, Vaskinn A et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr Bull 2011;37:73-83.
48. Kaya E, Aydemir O, Selcuki D. Residual symptoms in bipolar disorder: the effect of the last episode after remission. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:1387-1392.
49. Cubukcuoglu Z, Aydemir O. Specifity and sensitivity of neurocognitive tests in bipolar disorder: A comparative study. Unpublished thesis, 2011.
50. Hellvin T, Sundet K, Simonsen C et al. Neurocognitive functioning in patients recently diagnosed with bipolar disorder. Bipolar Disord 2012;14:227-238.
51. Hamilton M. A rating scale for depression. J Neurol 1960;23:55-62.
52. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
53. Rush AJ, Carmody T, Reimitz PE. The inventory of depressive sympotmatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 2000;9:45-59.
54. Young RC, Briggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978;133:429-435.
55. Altman EG, Hedeker DR, Janicak PG, Peterson JL, Davis JM. The clinician-administered rating scale for mania (CARS-M): development, reliability, and validity. Biol Psychiatry 1994;36:124-134.
56. Bech P, Boewig TG, Dein E, Jacobsen O, Gram LF. Quantitative rating of manic states. Acta Psychiatr Scand 1975;59:1-6.
57. Nelson HE, Willison J. National adult reading test manual. 2nd ed. Windsor: NFER-Nelson, 1991.
58. Wechsler D. Wechsler abbreviated scale of intelligence (WASI). San Antonio, TX: Harcourt Assessment, 1999.
59. Wechsler D. Wechsler memory scale - revised. New York: Psychological Corporation, 1987.
60. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
61. Nuechterlein KH, Green MF, Kern RS et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry 2008;165: 203-213.
62. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003;64:86-93.
63. Jamrozinski K, Gruber O, Kemmer C, Falkai P, Scherk H. Neurocognitive functions in euthymic bipolar patients. Acta Psychiatr Scand 2009;119:365-374.
64. Goswami U, Sharma A, Varma A et al. The neurocognitive performance of drug-free and medicated euthymic patients do not differ. Acta Psychiatr Scand 2009;120:456-463.
65. Glahn DC, Bearden CE, Barguil M et al. The neurocognitive signature of psychotic bipolar disorder. Biol Psychiatry 2007;62:910-916.
66. Glahn DC, Therman S, Manninen M et al. Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry 2003;53:624-626.
67. Glahn DC, Bearden CE, Cakira S et al. Differential working memory impairment in bipolar disorder and schizophrenia: effects of lifetime history of psychosis. Bipolar Disord 2006;8:117-123.
68. Torrent C, Martinez-Arán A, Daban C et al. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients. Compr Psychiatry 2011;52:203-213.
69. Mohamed S, Paulsen JS, O'leary D, Arndt S, Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry 1999;56: 749-754.
70. Cohen JW. Statistical power analysis for the behavioural sciences. 2nd ed. Hillsdale NJ: Lawrence Erlbaum Associates, 1988.
71. Kempton MJ, Geddes J, Ettinger U, Williams SCR, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008;65:1017-1032.
72. Vederine FE, Wessa M, Leboyer M, Houenou J. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1820-1826.
73. Andreazza AC, Kauer-Sant'anna M, Frey BN et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008;111:135-144.
74. Shao L, Young LT, Wang J. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 2005;58:879-884.
75. Tan H, Young LT, Shao L, Che Y, Honer WG, Wang J. Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex. Int J Neuropsychopharmacol 2012;15:1275-1285.
76. Mora E, Portella MJ, Forcada I, Vieta E, Mur M. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol Med 2013;43:1187-1196.
77. Torrent C, Martinez-Arán A, del Mar Bonnin C et al. Long-term outcome of cognitive impairment in bipolar disorder. J Clin Psychiatry 2012;73:e899-e905.
78. Ioannidis JPA. Why most published research findings are false. PLoS Med 2005;2:e124.